Diagnosis and treatment of diseases of the small intestine remain difficult and time consuming, with poor patient tolerance and uncertain outcome. Currently 50 to 100 patients with upper gastrointestinal bleeding are admitted to hospitals per 100,000 population per annum. In 5% of these cases, there will be no identifiable source of blood loss, despite exhaustive testing. Improved means for diagnosis and treatment for these patients are required to reduce their 10% mortality rate. Merix proposes to develop and demonstrate a prototype system which will permit rapid, safe, routing examination of the entire small intestine, to locate and identify sites of gastrointestinal bleeding. By modifying an approach which Merix has demonstrated for facilitated colonoscope insertion, we will be able to insert a diagnostic endoscopic probe from the nose to the terminal ileum in less that 30 minutes, without patient discomfort. This procedure will allow routine examination of the 14' of small intestine which presently can only be viewed by procedures which are potentially dangerous or very time consuming. The procedure also has the potential for enabling, for the first time therapeutic enteroscopic treatment of this region as well.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA051588-01A1
Application #
3492474
Study Section
Special Emphasis Panel (SSS (B4))
Project Start
1990-09-01
Project End
1991-11-30
Budget Start
1990-09-01
Budget End
1991-11-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Merix Corporation
Department
Type
DUNS #
City
Needham Heights
State
MA
Country
United States
Zip Code
02194